IACCARINO, Ciro
 Distribuzione geografica
Continente #
NA - Nord America 3.001
AS - Asia 1.739
EU - Europa 945
SA - Sud America 914
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 6
Totale 6.686
Nazione #
US - Stati Uniti d'America 2.921
BR - Brasile 812
SG - Singapore 630
CN - Cina 512
UA - Ucraina 229
IT - Italia 227
VN - Vietnam 192
DE - Germania 128
HK - Hong Kong 108
SE - Svezia 58
FI - Finlandia 57
GB - Regno Unito 57
FR - Francia 55
IN - India 43
TR - Turchia 34
MX - Messico 33
BD - Bangladesh 30
KR - Corea 30
AR - Argentina 27
RU - Federazione Russa 26
CA - Canada 25
IQ - Iraq 25
ZA - Sudafrica 23
EC - Ecuador 22
PL - Polonia 21
NL - Olanda 20
JP - Giappone 19
BE - Belgio 16
PK - Pakistan 16
UZ - Uzbekistan 16
CO - Colombia 13
ID - Indonesia 12
MA - Marocco 12
SA - Arabia Saudita 12
VE - Venezuela 11
KE - Kenya 10
PY - Paraguay 10
ES - Italia 9
TN - Tunisia 9
CZ - Repubblica Ceca 7
JO - Giordania 7
UY - Uruguay 7
KZ - Kazakistan 6
LT - Lituania 6
PA - Panama 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
AZ - Azerbaigian 5
EG - Egitto 5
PE - Perù 5
BO - Bolivia 4
DZ - Algeria 4
IL - Israele 4
LB - Libano 4
MD - Moldavia 4
PH - Filippine 4
PS - Palestinian Territory 4
SN - Senegal 4
AO - Angola 3
DO - Repubblica Dominicana 3
EU - Europa 3
HN - Honduras 3
IR - Iran 3
KG - Kirghizistan 3
KW - Kuwait 3
MY - Malesia 3
PT - Portogallo 3
AL - Albania 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
DM - Dominica 2
ET - Etiopia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
ZW - Zimbabwe 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CG - Congo 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IE - Irlanda 1
IM - Isola di Man 1
JM - Giamaica 1
KH - Cambogia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
ML - Mali 1
NG - Nigeria 1
Totale 6.682
Città #
Dallas 1.313
Singapore 330
Chandler 303
San Jose 174
Jacksonville 136
Ashburn 127
Beijing 126
Hong Kong 106
Sassari 90
Princeton 84
Ho Chi Minh City 70
Nanjing 64
Ann Arbor 62
New York 51
São Paulo 48
Lauterbourg 45
Shanghai 44
Dearborn 37
Hanoi 36
Los Angeles 31
Seoul 30
Wilmington 29
Nanchang 27
Santa Clara 25
Belo Horizonte 22
Helsinki 22
Boardman 21
Shenyang 21
Frankfurt am Main 20
Rio de Janeiro 20
Tianjin 20
Jinan 19
Warsaw 19
Council Bluffs 17
Tokyo 17
Brussels 16
Tashkent 16
Hebei 15
Johannesburg 15
Curitiba 14
Poplar 14
Woodbridge 14
Changsha 13
Munich 13
Orem 13
Stockholm 13
San Francisco 12
Da Nang 10
Guangzhou 10
Mexico City 10
Zhengzhou 10
Brasília 9
Brooklyn 9
Campo Grande 9
Chicago 9
Haiphong 9
Mountain View 9
Ningbo 9
Toronto 9
Baghdad 8
Betim 8
Boston 8
Cagliari 8
Campinas 8
Columbus 8
Dhaka 8
Guarulhos 8
Joinville 8
Mumbai 8
Nairobi 8
Niterói 8
Pelotas 8
Quito 8
Salvador 8
Amsterdam 7
Chennai 7
Denver 7
Guayaquil 7
Istanbul 7
Juiz de Fora 7
Norwalk 7
Porto Alegre 7
Ribeirão Preto 7
The Dalles 7
Amman 6
Atlanta 6
Bragança Paulista 6
Cotia 6
Haikou 6
Izmir 6
Jeddah 6
Lappeenranta 6
Manchester 6
Montevideo 6
Montreal 6
Nuremberg 6
Osasco 6
Rome 6
Sumaré 6
Taizhou 6
Totale 4.172
Nome #
null 509
Design, anticancer activity, and mechanistic evaluation of a novel class of selective human carbonic anhydrase IX inhibitors featuring a trifluorodihydroxypropanone pharmacophore 245
Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors 192
Prune melanoidins protect against oxidative stress and endothelial cell death 187
ALTERATION IN VESICLE TRAFFICKING IN PARKINSON’S DISEASE: FROM PATHOLOGICAL MOLECULAR MECHANISMS TO THERAPEUTIC OPTION 183
Role of LRRK2 in the regulation of dopamine receptor trafficking. 182
Epigenetic changes associated with the expression of Amyotrophic Lateral Sclerosis (ALS) causing genes 179
LRRK2 Modulates the Exocyst Complex Assembly by Interacting with Sec8 176
Cyanotoxins exposure and TDP-43 physiopathology: a molecular study 162
Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype 161
AMYOTROPHIC LATERAL SCLEROSIS AND TDP-43: AN EPIGENETIC LIAISON 161
Bcl2-A1 interacts with pro-caspase-3: Implications for amyotrophic lateral sclerosis 149
Alternative splicing of pro- and anti-apoptotic genes in amyotrophic lateral sclerosis 144
Apoptotic mechanisms in mutant LRRK2-mediated cell death 141
Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities 141
Dual control of dopamine synthesis and release by pre- and postsynaptic dopamine D2 receptors 140
Functional analysis of TDP43: interaction with the epigenetic machinery 139
Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways 139
EFFECT OF LRRK2 PATHOLOGICAL MUTATION ON DOPAMINE METABOLISM IN PC12 CELLS 137
Redox-sensitive GFP to monitor oxidative stress in neurodegenerative diseases 137
HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo 137
Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis 136
Control of Lactotrop Proliferation by Dopamine: Essential Role of Signalling Through D2 Receptors and ERKs 133
Cyanobacteria, cyanotoxins, and neurodegenerative diseases: Dangerous liaisons 131
Astroglial inhibition of NF-κB does not ameliorate disease onset and progression in a mouse model for Amyotrophic Lateral Sclerosis (ALS) 130
Astroglial inhibition of NF-kappaB does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis (ALS) 130
Inhibition of receptor-dependent urokinase signalling by specific Ser to Glu substitutions 125
Bcl2a1 role in familial Amyotrophic Lateral Sclerosis (ALS) 119
GFP-based reporters to monitor biochemical alteration in cellular models for Amyotrophic Lateral Sclerosis 117
Neurobiological features of dopamine D2 receptors. Distinct functions of D2L and D2S in vivo 116
Role of LRRK2 in the regulation of dopamine receptor trafficking 116
The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity 109
Natural polyphenols for one pot green synthesis and stabilization of gold nanoparticles with antioxidant and biological activities 106
Evaluation of Neuroinflammatory Contribution to Neurodegeneration in LRRK2 Drosophila Models 105
LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson’s Disease 105
Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility 105
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 105
Understanding the function of dopamine D2 receptor : A knock-out animal approach 103
Inhibition of the Exocyst Complex Attenuates the LRRK2 Pathological Effects 96
LRRK2 and vesicle trafficking 96
Regulatory roles of hnRNP M and Nova-1 in the alternative splicing of the dopamine D2 receptor pre-mRNA 94
SOD1-LINKED FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS: UNDERSTANDING THE TOXIC FUNCTION OF THE MUTANT ENZYMES 93
Parkinson’s disease-related genes and lipid alteration 92
PROTEIN KINASE C-DEPENDENT IN VIVO PHOSPHORYLATION OF PROUROKINASE LEADS TO THE FORMATION OF A RECEPTOR COMPETITIVE ANTAGONIST 90
Evaluation of cyanotoxin L-BMAA effect on α-synuclein and TDP43 proteinopathy 89
LRRK2 affects vesicle trafficking, neurotransmitter extracellular level and membrane receptor localization 77
Prune melanoidins protect endothelial cell against oxidative stress and mitochondria-mediated cell death 74
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 73
PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific manner 68
Design, anticancer activity, and mechanistic evaluation of a novel class of selective human carbonic anhydrase IX inhibitors featuring a trifluorodihydroxypropanone pharmacophore 38
Cyanobacteria and cyanotoxins: a long history of studies in Sardinia (Italy) 33
Totale 6.745
Categoria #
all - tutte 22.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.847


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 0 0 0 0 43 10 6
2021/2022261 23 2 7 5 2 9 8 12 36 40 27 90
2022/2023542 50 61 15 94 45 86 4 66 79 5 27 10
2023/2024218 24 13 2 8 24 35 24 5 0 11 34 38
2024/20251.665 7 8 102 49 80 65 120 315 514 262 93 50
2025/20263.044 139 400 1.094 385 244 160 376 60 87 99 0 0
Totale 6.745